[The reclassification assistant: Drug reclassification made easy]
P Schnetzer1, F Stucki2, D Heim2
1Institut für Veterinärpharmakologie und -toxikologie, Vetsuisse-Fakultät, Universität Zürich.
Schweizer Archiv Fur Tierheilkunde
|May 31, 2019
Summary
Veterinarians can use a new online assistant to determine if and how to reclassify veterinary medicines for livestock and horses when authorized options are unavailable. This tool ensures compliance with food safety regulations and provides crucial withdrawal period information.
Area of Science:
- Veterinary Medicine
- Pharmacology
- Food Safety Regulations
Background:
- Over 700 veterinary medicinal products are authorized in Switzerland.
- Veterinarians face challenges with unavailable or inapplicable authorized medicines, especially for livestock and horses.
- Food safety regulations complicate pharmacotherapy in these extraordinary situations.
Purpose of the Study:
- To introduce an online reclassification assistant for veterinary medicinal products.
- To guide veterinarians through the process of reclassifying medicines for food-producing animals.
- To ensure pharmacotherapy compliance with legal frameworks and food safety.
Main Methods:
- Development of an online assistant with a step-by-step, selectable option guidance.
- Algorithm based on the reclassification cascade and Swiss food safety regulations.
- Integration of information on withdrawal periods for reclassified medicines.
Main Results:
- The assistant determines the permissibility of reclassification within the legal framework.
- Provides essential information on withdrawal periods for selected veterinary medicines.
- Facilitates correct application of medicinal products in food-producing animals.
Conclusions:
- The online reclassification assistant addresses critical pharmacotherapy challenges for veterinarians.
- It supports safe and legal use of veterinary medicines in food-producing animals.
- Ensures adherence to food safety and regulatory requirements in veterinary practice.
Keywords:
AbsetzfristenAnimaux de renteCascade de reconversionDélai d’attenteEquidaeEquidenEquidésFarm animalsFood safetyLebensmittelsicherheitNutztiereReclassification cascadeSécurité alimentaireTermini di attesaUmwidmungskaskadeWithdrawal periodanimali da redditocascata per il cambiamento di destinazioneequinisicurezza delle derrate alimentari
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
399
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
399
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
155
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
155
01:26FDA Approved Drugs: Changes to Approved Drugs
248
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
248
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.1K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
462
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
462
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
226
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
226